According to a new report, published by KBV research, The Global Facial Aesthetics Market size is expected to reach $15.2 billion by 2028, rising at a market growth of 14.5% CAGR during the forecast period.
The Microdermabrasion segment is showcasing a CAGR of 15.2% during (2022 - 2028). By minimizing early sun damage, light, and shallow acne scars, microdermabrasion can boost skin tone and texture. Even with just one treatment, the skin may smooth out considerably and absorb moisturizers more effectively. It makes the skin look more nourished and naturally soft. Hence, this factor is driving the growth of this segment of the facial aesthetics market.
The Facial line correction treatment segment acquired maximum revenue share in the Global Facial Aesthetics Market by Application in 2021 thereby, achieving a market value of $6 billion by 2028. The growth of this segment of the market is expediting as a result of the rising geriatric population who develop facial lines and the rising demand for facial line correction treatment procedures. The number of people with age over 60 is rising.
The Specialty & Dermatology Clinics segment has shown the growth rate of 14.7% during (2022 - 2028). The growth of the segment is boosted due to the rising prevalence of skin conditions, like hyperpigmentation, acne, scars, and stretch marks as well as the rise in the number of specialists treating facial aesthetics in dermatology clinics. This type of clinics offers specialized services to their patients in order to fulfill their demands and deliver the best-in-class treatment experience.
The North America market dominated the Global Facial Aesthetics Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $5.6 billion by 2028. The Europe market is exhibiting a CAGR of 14.2% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 15.2% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/facial-aesthetics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.
By Product
By Application
By End User
By Geography
Companies Profiled
Unique Offerings 
